Comparison Coeptis Therapeutics Holdings Inc. Common Stock (COEP) with Competitors
Coeptis Therapeutics Holdings Inc. Common Stock (COEP) industry is Biotechnology.
Debt-to-Equity
COEP0.87%
Industry29.76%
Upside-97.07%
Free Cash Flow Yield
COEP-36.42%
Industry-1.94%
Upside-34.48%
P/E
COEP-1.38
Industry-18.88
Upside+1750.29%